Jackie Garza-Rothrock’s general civil litigation practice focuses on prosecuting and defending breach of contract, breach of fiduciary relationship, fraud and securities violations. Her civil practice also involves the defense of derivative suits and qui tam/false claims cases. Jackie provides counsel in all aspects of the process, including federal and state courts in Texas, preparing/defending pre-trial motions, discovery and trial. Prior to re-joining Bracewell, Jackie was in-house counsel at a large financial services group where she advised senior management and the board of directors on corporate governance matters.
Jackie also represents clients in arbitration, grand jury investigations and other criminal defense matters, including matters involving securities, antitrust and banking. Her regulatory work is focused primarily on Securities and Exchange Commission matters. In addition, Jackie has experience in corporate internal investigations and advising on corporate governance matters. She also counsels clients on public finance matters.
Recent Notable Matters
Tim Duncan — lead associate in actions prosecuted on behalf of former NBA player for the San Antonio Spurs against his former financial advisors, Charles Banks, for breach of fiduciary relationship, fraud, securities violations and related causes of action
Bexar County, Texas — cross-action against a surety to a performance bond for the performance of an IT contract for the acquisition and implementation of an integrated justice system, which resulted in a $2.9 million settlement
Multi-national auto parts manufacturer — lead associate conducting international internal investigation for this client into criminal antitrust allegations
Senior vice-president of Fortune 500 company — lead associate defending this client in an SEC investigation and enforcement action involving resale transaction revenue accounting, which resulted in no action against this individual
Numerous individuals and companies — defense in connection to federal civil and criminal investigations conducted by the FBI, DEA, U.S. Attorney’s Offices, HHS-OIG, Securities and Exchange Commission, and FINRA